Connect with us

Business

Hives Treatment Developer Third Harmonic Prices Upsized $185M IPO

Daniel

Published

on

Mikko Lemola

Hives treatment developer Third Harmonic Bio (THRD) has priced its upsized $185M initial public offering.

The biotech company said it now plans to offer 10.9M shares at $17 per share. Underwriters will be granted a 30-day option to buy up to 1.64M additional shares.

Morgan Stanley, Jefferies and Cowen are serving as joint bookrunners, with LifeSci Capital acting as co-manager.

Based in Cambridge, Mass., Third Harmonic’s lead product, THB001, is a KIT inhibitor being developed as a possible treatment for chronic uticaria, also known as hives.

The deal was upsized from an earlier proposal this month that had the company offering 9M shares priced between $16 and $18, which would have raised approximately $153M if priced at the midpoint.

Read More

Source Here: seekingalpha.com

Business

Oil and Gas Producer TXO Energy Sets Terms for Proposed $100M IPO

Daniel

Published

on

DariaRen

Oil and gas company MorningStar Partners, also known as TXO Energy Partners (TXO), has set terms for a proposed $100M initial public offering.

TXO said in its latest filing that it is now looking to offer 5M units, representing limited partners interests, priced between $19 and $21, which would raise $100M if priced at the midpoint. Proceeds from the deal would go in part to pay down debt.

Read More

Source Here: seekingalpha.com

Continue Reading

Business

Hypertension Drug Developer Mineralys Therapeutics Files for $100M IPO

Daniel

Published

on

Andranik Hakobyan

Hypertension drug developer Mineralys Therapeutics (MLYS) has filed for a $100M initial public offering.

The biotech company didn’t specify in its filing the price or number of shares to be offered, but indicated in its filing fee schedule that it was seeking $100M, a figure that is likely a placeholder and subject to change.

Read More

Original Article: seekingalpha.com

Continue Reading

Business

Oil Extends Gains As China Optimism Outweighs Big Jump in U.S. Stockpiles

Daniel

Published

on

SlavkoSereda/iStock via Getty Images

U.S. crude oil advanced for the fifth straight session Wednesday, despite a U.S. government report showing a massive build in domestic crude inventories.

The Energy Information Administration reported U.S. crude stockpiles surged by 19M barrels – the third largest weekly increase since EIA records began in 1982 – which analysts said largely reflects the following shut-ins during last month’s winter storm.

Read More

Original Source: seekingalpha.com

Continue Reading

Trending

MQRV.com